Chemoinformaics analysis of cyclo-dopa 5-O-glucoside
| Molecular Weight | 357.315 | nRot | 4 |
| Heavy Atom Molecular Weight | 338.163 | nRig | 16 |
| Exact Molecular Weight | 357.106 | nRing | 3 |
| Solubility: LogS | -1.866 | nHRing | 2 |
| Solubility: LogP | -1.844 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 25 | No. of Aromatic Carbocycles | 1 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 19 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 6 |
| nHA | 9 | APOL | 46.0371 |
| nHD | 7 | BPOL | 23.9709 |
| QED | 0.289 |
| Synth | 4.141 |
| Natural Product Likeliness | 1.827 |
| NR-PPAR-gamma | 0.005 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.692 |
| HIA | 0.886 |
| CACO-2 | -6.147 |
| MDCK | 0.00027485 |
| BBB | 0.722 |
| PPB | 0.298607 |
| VDSS | 0.654 |
| FU | 0.592915 |
| CYP1A2-inh | 0.044 |
| CYP1A2-sub | 0.037 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.067 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.21 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.2 |
| CYP3a4-inh | 0.004 |
| CYP3a4-sub | 0.006 |
| CL | 1.51 |
| T12 | 0.783 |
| hERG | 0.025 |
| Ames | 0.318 |
| ROA | 0.026 |
| SkinSen | 0.049 |
| Carcinogencity | 0.087 |
| EI | 0.009 |
| Respiratory | 0.43 |
| NR-Aromatase | 0.025 |
| Antiviral | No |
| Prediction | 0.564858 |